Assenagon Asset Management
KURA icon

Assenagon Asset Management’s Kura Oncology KURA Stock Holding History

Assenagon Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Sell
267,748
-71,964
-21% -$679K ﹤0.01% 780
2026
Q1 		$2.76M Sell
339,712
-805,304
-70% -$6.92M ﹤0.01% 721
2025
Q4 		$11.9M Sell
1,145,016
-120,014
-9% -$1.26M 0.02% 472
2025
Q3 		$11.2M Buy
1,265,030
+345,951
+38% +$2.47M 0.02% 462
2025
Q2 		$5.3M Hold
919,079
– – 0.01% 564
2025
Q1 		$6.07M Buy
919,079
+13,895
+2% +$108K 0.01% 511
2024
Q4 		$7.88M Sell
905,184
-146,879
-14% -$2.11M 0.01% 567
2024
Q3 		$20.6M Sell
1,052,063
-679,514
-39% -$13.8M 0.04% 335
2024
Q2 		$35.7M Buy
1,731,577
+577,732
+50% +$11.9M 0.08% 190
2024
Q1 		$24.6M Hold
1,153,845
– – 0.06% 244
2023
Q4 		$16.6M Hold
1,153,845
– – 0.04% 333
2023
Q3 		$10.5M Hold
1,153,845
– – 0.03% 372
2023
Q2 		$12.2M Hold
1,153,845
– – 0.04% 320
2023
Q1 		$14.1M Hold
1,153,845
– – 0.05% 312
2022
Q4 		$14.3M Sell
1,153,845
-2,642
-0.2% -$38.4K 0.05% 311
2022
Q3 		$15.8M Hold
1,156,487
– – 0.06% 270
2022
Q2 		$21.2M Sell
1,156,487
-523,709
-31% -$7.53M 0.08% 220
2022
Q1 		$27M Buy
1,680,196
+1,158,356
+222% +$16.7M 0.08% 208
2021
Q4 		$7.31M Sell
521,840
-316,493
-38% -$5.13M 0.02% 414
2021
Q3 		$15.7M Buy
838,333
+304,254
+57% +$5.73M 0.05% 233
2021
Q2 		$11.1M Buy
534,079
+415,879
+352% +$10.3M 0.04% 325
2021
Q1 		$3.34M Hold
118,200
– – 0.01% 595
2020
Q4 		$3.86M Sell
118,200
-205,200
-63% -$7.21M 0.02% 407
2020
Q3 		$9.91M Buy
+323,400
New +$7.14M 0.06% 199
2018
Q3 		– Sell
-20,602
Closed -$375K – 802
2018
Q2 		$375K Sell
20,602
-24,693
-55% -$418K ﹤0.01% 415
2018
Q1 		$849K Buy
+45,295
New +$882K 0.01% 426

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Assenagon Asset Management's KURA Position: Q2 2026 in Review

Assenagon Asset Management reduced its Kura Oncology (KURA) stake by 21% in Q2 2026, selling an estimated $679K and leaving 267,748 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #780.

Assenagon Asset Management first reported a position in KURA in Q1 2018 and has held it in 26 quarters since. The position peaked at $35.7M in Q2 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Assenagon Asset Management held 267,748 shares of Kura Oncology worth $2.94M as of Q2 2026.
  • Assenagon Asset Management sold 71,964 Kura Oncology shares in Q2 2026, an estimated $679K.
  • Kura Oncology made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #780 holding.
  • Assenagon Asset Management first reported a position in Kura Oncology in Q1 2018 and has held it in 26 quarters since.
  • Assenagon Asset Management's Kura Oncology position peaked at $35.7M in Q2 2024.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.